Biotech and Life Sciences jobs in Cambridge hiring now at vetted startups and product companies on Alion, updated daily. Average salary around $243,387/year. Compare remote, hybrid and on-site positions with relocation and visa sponsorship. Browse and apply today.
astrazeneca.com · HQ: Cambridge, United Kingdom · Rare Disease Therapeutics · Cardiometabolic Therapeutics · Oncology Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1999 · Trust A · Hiring 811, 165 new
HQ: Cambridge, United Kingdom · Rare Disease Therapeutics · Cardiometabolic Therapeutics · Oncology Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1999 · Trust A · Hiring 811, 165 new
AstraZeneca is a British-Swedish pharmaceutical company formed in 1999 by the merger of Astra of Sweden and Zeneca of the United Kingdom, and now one of the largest drug makers in the world by revenue. Its portfolio is concentrated in oncology with Tagrisso, Imfinzi and Enhertu, alongside cardiovascular, renal and metabolic products including Farxiga, respiratory and immunology medicines, and a rare disease business built on the acquisition of Alexion. Headquartered in Cambridge in England and listed in London, Stockholm and New York, it reports in United States dollars.
amgen.com · HQ: Thousand Oaks, United States · Immunology & Inflammation Therapeutics · Cardiometabolic Therapeutics · Prescription Drugs · Biologics & Biosimilars · 5000+ employees · Est. 1980 · Trust B · Hiring 1230, 127 new
HQ: Thousand Oaks, United States · Immunology & Inflammation Therapeutics · Cardiometabolic Therapeutics · Prescription Drugs · Biologics & Biosimilars · 5000+ employees · Est. 1980 · Trust B · Hiring 1230, 127 new
Amgen is an American biotechnology company founded in Thousand Oaks in 1980 that became one of the first firms to turn recombinant protein research into large commercial medicines. Its history rests on Epogen and Neupogen, and its current portfolio spans bone health with Prolia and Evenity, inflammation with Otezla and Tezspire, cardiovascular disease with Repatha, oncology including the bispecific antibody Blincyto, and a biosimilars business built on its own manufacturing capacity. The company is listed on Nasdaq, is a component of the Dow Jones Industrial Average, and expanded further into rare disease through its acquisition of Horizon Therapeutics.
scholarrock.com · HQ: Cambridge, United States · Rare Disease Therapeutics · Biologics & Biosimilars · Est. 2012 · Trust B · Hiring 30, 4 new
HQ: Cambridge, United States · Rare Disease Therapeutics · Biologics & Biosimilars · Est. 2012 · Trust B · Hiring 30, 4 new
We create new possibilities through cutting-edge science. At Scholar Rock, we are on a mission to discover, develop, and deliver therapies to improve people’s lives.
pfizer.com · HQ: New York, United States · Infectious Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1849 · Trust A · Hiring 343, 102 new
HQ: New York, United States · Infectious Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1849 · Trust A · Hiring 343, 102 new
Pfizer is an American multinational pharmaceutical and biotechnology company headquartered in New York City, developing, manufacturing and marketing prescription medicines and vaccines in areas such as oncology, internal medicine, inflammation and immunology, and infectious diseases. Founded in 1849 by Charles Pfizer and Charles Erhart, it is listed on the New York Stock Exchange and operates research and manufacturing sites across the US, Europe and Asia, including a digital hub in Thessaloniki and large commercial teams in China. Its board hires medical information specialists, quality assurance and GMP audit managers, marketing leads, accountants, engineers and AI experience designers.
$124k – $207k per year · Senior · 7+ years exp · In office (New York, Cambridge, United States) · Relocation · Master's Degree · Full-Time · Senior · English
flagshippioneering.com · HQ: Cambridge, United States · Venture Capital · 1001-5000 employees · Est. 2000 · Trust B · Hiring 86, 14 new
HQ: Cambridge, United States · Venture Capital · 1001-5000 employees · Est. 2000 · Trust B · Hiring 86, 14 new
Flagship Pioneering is a life sciences venture creation firm headquartered in Cambridge, Massachusetts, that conceives, founds, funds and builds biotechnology companies. Founded in 2000 by Noubar Afeyan, it has created companies such as Moderna and runs in-house laboratories where its scientists develop platforms before they are spun out as new ventures. It hires scientists in protein science, structural biology, biochemistry and formulation, machine learning interns and platform leaders, mostly in Cambridge.
bms.com · HQ: Princeton, United States · Cardiometabolic Therapeutics · Biologics & Biosimilars · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1887 · Trust A · Hiring 362, 79 new
HQ: Princeton, United States · Cardiometabolic Therapeutics · Biologics & Biosimilars · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1887 · Trust A · Hiring 362, 79 new
Bristol Myers Squibb is an American pharmaceutical company whose predecessors date to 1858 and 1887 and which took its present form in a 1989 merger. Its portfolio is concentrated in oncology, haematology, immunology and cardiovascular disease, including the checkpoint inhibitor Opdivo, the blood thinner Eliquis co-marketed with Pfizer, the cell therapies acquired with Celgene, and newer products such as the schizophrenia treatment Cobenfy. Headquartered in Princeton, New Jersey and listed on the New York Stock Exchange, it faces a heavy sequence of patent expiries and has been buying and licensing assets to replace them.
biogen.com · HQ: Cambridge, United States · Prescription Drugs · Neurology & CNS Therapeutics · 1001-5000 employees · Est. 1978 · NASDAQ: BIIB · Trust B · Hiring 184, 20 new
HQ: Cambridge, United States · Prescription Drugs · Neurology & CNS Therapeutics · 1001-5000 employees · Est. 1978 · NASDAQ: BIIB · Trust B · Hiring 184, 20 new
Biogen is an American biotechnology company headquartered in Cambridge, Massachusetts, that develops and sells therapies for neurological and neurodegenerative diseases. Founded in 1978, its products treat multiple sclerosis, spinal muscular atrophy, Alzheimer's disease and other rare and neuromuscular disorders. It is listed on Nasdaq and hires regulatory, manufacturing, medical science liaison and IT staff in Cambridge, Research Triangle Park, Baar and other sites.
sanofi.com · HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 706, 105 new
HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 706, 105 new
Sanofi is a French pharmaceutical company formed in 1973 and assembled over five decades through a long series of mergers including Synthelabo, Aventis and Genzyme. It is now built around immunology and rare disease, with Dupixent for atopic dermatitis and asthma as by far its largest product, alongside a substantial vaccines division covering influenza, meningitis and the respiratory syncytial virus antibody Beyfortus. Headquartered in Paris, the group has sharpened its focus in recent years by separating its consumer healthcare business into the standalone company Opella and directing research spending toward biologics and immune science.
broadinstitute.org · HQ: Cambridge, United States · Nonprofits & Foundations · Genomics & Genetic Testing · Bioinformatics · Research Institutes · 501-1000 employees · Est. 2004 · Hiring 29, 2 new
HQ: Cambridge, United States · Nonprofits & Foundations · Genomics & Genetic Testing · Bioinformatics · Research Institutes · 501-1000 employees · Est. 2004 · Hiring 29, 2 new
The Broad Institute is a biomedical and genomic research centre founded jointly by MIT and Harvard to tackle problems that need scale beyond a single university laboratory. Its data sciences platform develops machine learning methods for genomics, cancer biology and drug discovery, and maintains widely used open tools, datasets and cloud analysis platforms. The institute also runs one of the largest genome sequencing operations in the world; its researchers work jointly with the two universities and with hospitals across the Boston area.
Novartis is a Swiss pharmaceutical company created in 1996 by the merger of Ciba-Geigy and Sandoz, two Basel chemical and drug houses with roots in the nineteenth century. It has spent the past decade narrowing itself into a pure innovative medicines business, spinning off its generics arm as Sandoz in 2023 and its eye care business as Alcon in 2019, and now concentrates on cardiovascular, immunology, neuroscience and oncology, including radioligand therapies and gene therapy. Headquartered in Basel and listed in Zurich and New York, it is among the largest research spenders in the industry.
amylyx.com · Cambridge · Stockholm · Cork · Rare Disease Therapeutics · 51-200 employees · Trust B · Hiring 39, 6 new
Cambridge · Stockholm · Cork · Rare Disease Therapeutics · 51-200 employees · Trust B · Hiring 39, 6 new
Ushering in a new era for treating diseases with high unmet needs. We have an audacious mission to develop novel therapies for communities with high unmet needs. Where others see obstacles, the Amylyx team sees opportunities to find solutions for some of medicine's toughest challenges.
alnylam.com · HQ: Cambridge, United States · Cardiometabolic Therapeutics · Rare Disease Therapeutics · Cell & Gene Therapy · 51-200 employees · Est. 2002 · Trust A · Hiring 91, 7 new
HQ: Cambridge, United States · Cardiometabolic Therapeutics · Rare Disease Therapeutics · Cell & Gene Therapy · 51-200 employees · Est. 2002 · Trust A · Hiring 91, 7 new
Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, that develops and commercialises RNA interference therapeutics for rare and common diseases, including ATTR amyloidosis and acute hepatic porphyria. Founded in Cambridge in 2002 and listed on the Nasdaq, it has six approved medicines available in more than 70 countries, a manufacturing site in Norton, Massachusetts, a European base in Maidenhead and an affiliate in Tokyo. It hires research and biology scientists, quality control analysts, clinical science and regulatory affairs staff, field reimbursement and key account managers, and IT, cyber defense and HR technology leaders.
takeda.com · HQ: Tokyo, Japan · Neurology & CNS Therapeutics · Rare Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1781 · Trust A · Hiring 1115, 94 new
HQ: Tokyo, Japan · Neurology & CNS Therapeutics · Rare Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1781 · Trust A · Hiring 1115, 94 new
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise specializing in the research, development, and commercialization of targeted human therapeutics. The company focuses on core therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. Headquartered in Tokyo, Japan, it maintains extensive research, manufacturing, and commercial operations across more than 80 countries in Asia-Pacific, North America, Europe, and Latin America.
msd.com · HQ: Rahway, United States · Biologics & Biosimilars · Veterinary Medicine · Vaccines · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1891 · Trust A · Hiring 737, 184 new
HQ: Rahway, United States · Biologics & Biosimilars · Veterinary Medicine · Vaccines · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1891 · Trust A · Hiring 737, 184 new
Merck & Co. is an American pharmaceutical company founded in 1891 as the United States arm of the German firm Merck and made independent after the First World War, trading as MSD outside the United States and Canada. Its portfolio is dominated by the immuno-oncology drug Keytruda, alongside vaccines such as Gardasil and Vaxneuvance, hospital acute care products, and a large animal health business covering livestock and companion animals. The company is headquartered in Rahway, New Jersey, listed on the New York Stock Exchange, and spends a very large share of revenue on research into oncology, infectious disease and cardiometabolic therapies.
gsk.com · HQ: London, United Kingdom · Oncology Therapeutics · Infectious Disease Therapeutics · Vaccines · Prescription Drugs · 1001-5000 employees · Est. 2000 · Trust A · Hiring 699, 111 new
HQ: London, United Kingdom · Oncology Therapeutics · Infectious Disease Therapeutics · Vaccines · Prescription Drugs · 1001-5000 employees · Est. 2000 · Trust A · Hiring 699, 111 new
GSK is a British multinational pharmaceutical company that develops and manufactures prescription medicines and vaccines, with research focused on infectious diseases, HIV, respiratory and immunology, and oncology. It was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham and spun off its consumer healthcare business as Haleon in 2022. Listed in London and New York, it runs research, manufacturing and commercial operations worldwide. The company is headquartered in London, England, United Kingdom.
abbvie.com · HQ: North Chicago, Blacksburg, United States · Neurology & CNS Therapeutics · Oncology Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 5000+ employees · Est. 2013 · NYSE: ABBV · Trust B · Hiring 1062, 225 new
HQ: North Chicago, Blacksburg, United States · Neurology & CNS Therapeutics · Oncology Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 5000+ employees · Est. 2013 · NYSE: ABBV · Trust B · Hiring 1062, 225 new
AbbVie is an American biopharmaceutical company created in 2013 when Abbott Laboratories separated its research-based drug business into a standalone listed company. It was built around the immunology drug Humira, once the highest selling medicine in the world, and has since replaced that revenue with the successor immunology drugs Skyrizi and Rinvoq, an oncology portfolio led by Imbruvica and Venclexta, neuroscience products including Botox Therapeutic and Vraylar, and the aesthetics business acquired with Allergan. Headquartered in North Chicago and listed on the New York Stock Exchange, it is one of the largest pharmaceutical companies by revenue.
miraibio.com · HQ: Cambridge, United States · Cell & Gene Therapy · Drug Discovery AI · Drug Discovery · 51-200 employees · Startup · Hiring 3, 1 new
HQ: Cambridge, United States · Cell & Gene Therapy · Drug Discovery AI · Drug Discovery · 51-200 employees · Startup · Hiring 3, 1 new
Mirai Bio is a privately held biotechnology company founded by Flagship Pioneering that develops delivery technologies for genetic medicines. It combines a large proprietary in vivo biodistribution dataset with machine learning to target nucleic acid payloads to specific cells and tissues beyond the liver, including lipid nanoparticle formulation. The company is headquartered in Cambridge, Massachusetts.
primemedicine.com · HQ: Cambridge, United States · Cell & Gene Therapy · 501-1000 employees · Est. 2019 · NASDAQ: PRME · Hiring 11, 1 new
HQ: Cambridge, United States · Cell & Gene Therapy · 501-1000 employees · Est. 2019 · NASDAQ: PRME · Hiring 11, 1 new
Delivering on the promise of Prime Editing. Prime Medicine™ was founded with a goal of transforming the lives of patients with debilitating diseases through the application of our groundbreaking Prime Editing platform and technology.
beamtx.com · HQ: Cambridge, United States · Precision Medicine · Cell & Gene Therapy · Est. 2002 · NASDAQ: BEAM · Hiring 18, 1 new
HQ: Cambridge, United States · Precision Medicine · Cell & Gene Therapy · Est. 2002 · NASDAQ: BEAM · Hiring 18, 1 new
Beam Therapeutics is an American biotechnology company developing precision genetic medicines based on base editing, a gene editing technology designed for precise, predictable changes to DNA. It combines gene editing, delivery and in-house manufacturing in an integrated platform aimed at lifelong cures for serious diseases. The company is headquartered in Cambridge, Massachusetts.
